Yifan Pharmaceutical Co., Ltd. (SHE:002019)

China flag China · Delayed Price · Currency is CNY
12.70
+0.32 (2.58%)
Apr 15, 2026, 3:04 PM CST
Market Cap12.83B -7.0%
Revenue (ttm)5.22B +4.6%
Net Income407.37M
EPS0.34
Shares Out1.04B
PE Ratio36.44
Forward PEn/a
Dividend0.10 (0.79%)
Ex-Dividend DateMay 29, 2025
Volume34,336,183
Average Volume24,070,777
Open12.97
Previous Close12.38
Day's Range12.43 - 12.97
52-Week Range10.78 - 16.66
Beta0.83
RSI47.21
Earnings DateApr 24, 2026

About Yifan Pharmaceutical

Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products, raw materials, and polymer materials in Southeast Asia, Europe and North America, Singapore, South Korea, Italy, China, Germany, and the United States. It offers Chinese patent medicines, chemical medicines and biological medicines; and vitamin products, including vitamin B5 and original B5. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October... [Read more]

Sector Healthcare
Founded 2000
Employees 4,098
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002019
Full Company Profile

Financial Performance

Financial Statements